Chimeric antigen receptor T-cell (CAR-T) therapy provided to Medicare Advantage (MA) beneficiaries will be paid for by traditional Medicare for calendar years 2019 and 2020.
This week’s Medicare updates includes 2020 payment rates for the Medicare Diabetes Prevention Program, updates to the OIG work plan, guidance on coding for encounters related to vaping illnesses, and more!
A federal judge rejected CMS’ motion to reconsider or issue a stay on her September order to vacate cuts to reimbursement to grandfathered off-campus provider-based departments.
Q: Is there a recommended practice for how modifiers should be included in the chargemaster? Is it preferred to add them as a separate field or included in the HCPCS field?
This week’s Medicare updates include a pair of proposed rules on revisions to Stark Law, a correction notice for the IPPS final rule, updates to the amount in controversy thresholds for CY 2020, and more!
